EphA5 Activators
EphA5 activators comprise a diverse group of chemicals that influence various cellular signaling pathways, thereby indirectly affecting the activity of EphA5. These activators do not directly bind or activate EphA5; instead, they modulate the cellular environment and pathways that can lead to changes in EphA5 activity. The primary mechanism of action for these chemicals is through the modulation of kinase activities, PI3K/Akt signaling, cAMP/PKA pathways, and MAPK/ERK signaling. For example, compounds like Staurosporine and Genistein, though primarily acting as kinase inhibitors, can influence kinase signaling cascades in a way that potentially modulates pathways involving EphA5. Similarly, Forskolin's ability to elevate cAMP levels and subsequently enhance PKA activity can alter the signaling environment, indirectly impacting EphA5.
In addition, other chemicals such as LY294002, U0126, and PD98059 modulate key signaling pathways like PI3K/Akt and MAPK/ERK, which are crucial for various cellular processes. These modulations can lead to alterations in the signaling landscape, potentially influencing EphA5 activity. The action of compounds like Curcumin and Sildenafil Citrate, which affect a wide range of signaling pathways, further exemplifies the complexity of cellular signaling and its potential impact on specific receptors like EphA5. Rapamycin's influence on mTOR signaling and SB203580's impact on p38 MAPK pathway demonstrate another aspect of indirect modulation, where key regulatory pathways are targeted, leading to changes in the cellular context that might affect EphA5 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. While primarily an inhibitor, its broad spectrum activity can influence kinase signaling cascades, potentially affecting pathways that modulate EphA5 activity indirectly through kinase interactions. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, might indirectly affect EphA5 activity. By modulating tyrosine kinase signaling, Genistein can influence cellular pathways that intersect with those regulated by EphA5. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, could indirectly influence EphA5 by modulating the PI3K/Akt pathway. This pathway is crucial for various cellular processes, and its modulation could lead to changes in EphA5 signaling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels. Elevated cAMP can enhance PKA activity, which might indirectly influence EphA5 activity by altering the cellular signaling environment. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid with kinase inhibitory properties, could affect various signaling pathways, potentially altering EphA5 activity. Its broad impact on cellular signaling could lead to indirect modulation of EphA5. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that could indirectly affect EphA5 activity by modulating the MAPK/ERK pathway, potentially influencing cellular processes regulated by EphA5. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate various signaling pathways, including those involved in cell growth and differentiation. This broad spectrum of activity might indirectly affect EphA5 signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation. This inhibition could indirectly influence EphA5 signaling by altering cellular processes associated with EphA5. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By modulating this pathway, it could indirectly influence EphA5 activity through pathway cross-talk and signaling interaction. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, mimics the action of cAMP and can thus enhance PKA activity. This might indirectly affect EphA5 activity by altering the cellular signaling environment. | ||||||